Source-aware
We distinguish between primary research, registries, official information, and claims that are less clearly supported.
Tidal Arc
Tidal Arc is an independent resource on ibogaine’s time course, including acute effects, lingering pharmacology, and practical safety considerations. It helps people distinguish between what is known, uncertain, and highly individual.
Why this exists
Tidal Arc exists for people seeking clear, cautious context about how long ibogaine and noribogaine effects may last. The resource is built to make a complicated subject easier to navigate without turning uncertainty into false certainty.
Our starting point is the core duration material: explain what a source can support, identify what can vary from person to person, and keep practical risk considerations visible rather than incidental.
The site is independent. It does not direct people toward a particular provider, program, or outcome, and it does not substitute for individualized medical, legal, or emergency guidance.
Our editorial approach
Information is reviewed with attention to study design, source limitations, and the difference between descriptive material and advice. When a claim depends on formal research, Tidal Arc favors traceable literature and established public references, including the PubMed literature database, rather than promotional language.
We distinguish between primary research, registries, official information, and claims that are less clearly supported.
Technical ideas are organized in direct language so readers can see the limits as well as the headline.
Safety context is treated as central. The scope of our information work reflects that priority without presenting Tidal Arc as a provider.
What we cover
Tidal Arc organizes information around duration, effects, lingering pharmacology, and practical safety considerations. It also connects readers with context that may help them compare common questions without implying that one account applies to everyone.
Who this is for
This resource is for people looking for a calm, evidence-aware way to approach a difficult question. It is not designed to persuade anyone toward treatment, travel, or a particular protocol. Readers considering material about ibogaine treatment for addiction may use this site as context, not as a clinical recommendation.
“What is known, what remains uncertain, and what needs qualified individual assessment are different things.”
That distinction matters when sources discuss subjects such as ibogaine and 5-MeO-DMT, an ibogaine documentary, or a reported treatment success rate. Tidal Arc treats those materials as topics requiring context, rather than as proof of a personal outcome.
Independent by design
Tidal Arc is designed to be useful without overstating what a general resource can do. Its editorial approach recognizes that health-related questions can require individualized assessment, especially where risk, medication, or monitoring is involved. The U.S. Food and Drug Administration’s drug information illustrates why official information and professional assessment remain important parts of health decision-making.
For site updates or operator information, the available contact route is the appropriate place to start.